SIGMA HEALTHCARE LTD (SIG.AU) experienced a significant price surge intraday, with shares soaring 7.95%.
The sharp upward movement follows the company's announcement that it has withdrawn from preliminary talks to acquire UK pharmacy chain Boots. Sigma Healthcare concluded that a potential deal would not meet its strategic and capital investment objectives, despite initially considering it as a way to accelerate expansion in the United Kingdom.
The company reiterated its commitment to international growth as a key strategic pillar, stating it remains focused on expanding in core offshore markets while exploring opportunities in new regions. Investors appear to be responding positively to the decision to avoid a potentially costly acquisition that did not align with the company's investment criteria.